India to Thailand: Gabapentin Export Trade Route
India has recorded 57 verified shipments of Gabapentin exported to Thailand, representing a combined trade value of $2.2M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $38.7K USD. The leading Indian exporter is SANDOZ PRIVATE LIMITED , which accounts for 57% of total export value with 18 shipments worth $1.3M USD. On the buying side, Novartis (Thailand) Limited is the largest importer in Thailand with $1.3M USD in purchases. The top 3 suppliers — SANDOZ PRIVATE LIMITED , SANDOZ PRIVATE LIMITED, UNICORNS PHARMACEUTICALS — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Gabapentin corridor is one of India's established pharmaceutical export routes, with 57 shipments documented worth a combined $2.2M USD. The route is dominated by SANDOZ PRIVATE LIMITED , which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's gabapentin manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $38.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April-June, with an average transit time of 7 days port-to-port. The route has recorded an annual growth rate of 26.8%, placing it at rank #5 among India's top gabapentin export destinations globally.
On the import side, key buyers of Indian gabapentin in Thailand include Novartis (Thailand) Limited , SANDOZ (THAILAND) LIMITED, Novartis (Thailand) Limited and 13 others. Novartis (Thailand) Limited is the single largest importer with 18 shipments valued at $1.3M USD.
